Cushing's Syndrome and Acromegaly Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: C380993FAFA0EN
Market Monitor Global

Abstracts

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and Others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly involves symptoms such as enlargement of the hands, feet, forehead, jaw, nose etc. resulting in joint pain, thickening of skin, deepening of the voice, headaches, and vision problems. Others complications include type 2 diabetes, and hypertension. Acromegaly is also caused by production of excess growth hormone (GH). Most cases of Acromegaly is due to the pituitary gland producing excessive growth hormone mostly due a benign tumor, known as a pituitary adenoma.

This report contains market size and forecasts of Cushing's Syndrome and Acromegaly Treatment in Global, including the following market information:

Global Cushing's Syndrome and Acromegaly Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cushing's Syndrome and Acromegaly Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Glucocorticoid Receptor Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cushing's Syndrome and Acromegaly Treatment include Pfizer, Novartis, Bristol-Myers Squibb, Corcept Therapeutics, HRA Pharma and Ipsen Biopharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cushing's Syndrome and Acromegaly Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cushing's Syndrome and Acromegaly Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cushing's Syndrome and Acromegaly Treatment Market Segment Percentages, by Type, 2021 (%)

• Glucocorticoid Receptor Inhibitors
• Somatostatin
• Ketoconazole HRA
• Others

Global Cushing's Syndrome and Acromegaly Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cushing's Syndrome and Acromegaly Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Cushing's Syndrome and Acromegaly Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cushing's Syndrome and Acromegaly Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cushing's Syndrome and Acromegaly Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cushing's Syndrome and Acromegaly Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Novartis
• Bristol-Myers Squibb
• Corcept Therapeutics
• HRA Pharma
• Ipsen Biopharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cushing's Syndrome and Acromegaly Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cushing's Syndrome and Acromegaly Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CUSHING'S SYNDROME AND ACROMEGALY TREATMENT OVERALL MARKET SIZE

2.1 Global Cushing's Syndrome and Acromegaly Treatment Market Size: 2021 VS 2028
2.2 Global Cushing's Syndrome and Acromegaly Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cushing's Syndrome and Acromegaly Treatment Players in Global Market
3.2 Top Global Cushing's Syndrome and Acromegaly Treatment Companies Ranked by Revenue
3.3 Global Cushing's Syndrome and Acromegaly Treatment Revenue by Companies
3.4 Top 3 and Top 5 Cushing's Syndrome and Acromegaly Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cushing's Syndrome and Acromegaly Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cushing's Syndrome and Acromegaly Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Cushing's Syndrome and Acromegaly Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cushing's Syndrome and Acromegaly Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cushing's Syndrome and Acromegaly Treatment Market Size Markets, 2021 & 2028
  4.1.2 Glucocorticoid Receptor Inhibitors
  4.1.3 Somatostatin
  4.1.4 Ketoconazole HRA
  4.1.5 Others
4.2 By Type - Global Cushing's Syndrome and Acromegaly Treatment Revenue & Forecasts
  4.2.1 By Type - Global Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Cushing's Syndrome and Acromegaly Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cushing's Syndrome and Acromegaly Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Cushing's Syndrome and Acromegaly Treatment Revenue & Forecasts
  5.2.1 By Application - Global Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Cushing's Syndrome and Acromegaly Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cushing's Syndrome and Acromegaly Treatment Market Size, 2021 & 2028
6.2 By Region - Global Cushing's Syndrome and Acromegaly Treatment Revenue & Forecasts
  6.2.1 By Region - Global Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Cushing's Syndrome and Acromegaly Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2028
  6.3.2 US Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.3.3 Canada Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.3.4 Mexico Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2028
  6.4.2 Germany Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.4.3 France Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.4.4 U.K. Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.4.5 Italy Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.4.6 Russia Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.4.8 Benelux Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2028
  6.5.2 China Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.5.3 Japan Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.5.4 South Korea Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.5.6 India Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2028
  6.6.2 Brazil Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.6.3 Argentina Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2028
  6.7.2 Turkey Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.7.3 Israel Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028
  6.7.5 UAE Cushing's Syndrome and Acromegaly Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Cushing's Syndrome and Acromegaly Treatment Major Product Offerings
  7.1.4 Pfizer Cushing's Syndrome and Acromegaly Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Cushing's Syndrome and Acromegaly Treatment Major Product Offerings
  7.2.4 Novartis Cushing's Syndrome and Acromegaly Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Bristol-Myers Squibb
  7.3.1 Bristol-Myers Squibb Corporate Summary
  7.3.2 Bristol-Myers Squibb Business Overview
  7.3.3 Bristol-Myers Squibb Cushing's Syndrome and Acromegaly Treatment Major Product Offerings
  7.3.4 Bristol-Myers Squibb Cushing's Syndrome and Acromegaly Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bristol-Myers Squibb Key News
7.4 Corcept Therapeutics
  7.4.1 Corcept Therapeutics Corporate Summary
  7.4.2 Corcept Therapeutics Business Overview
  7.4.3 Corcept Therapeutics Cushing's Syndrome and Acromegaly Treatment Major Product Offerings
  7.4.4 Corcept Therapeutics Cushing's Syndrome and Acromegaly Treatment Revenue in Global Market (2017-2022)
  7.4.5 Corcept Therapeutics Key News
7.5 HRA Pharma
  7.5.1 HRA Pharma Corporate Summary
  7.5.2 HRA Pharma Business Overview
  7.5.3 HRA Pharma Cushing's Syndrome and Acromegaly Treatment Major Product Offerings
  7.5.4 HRA Pharma Cushing's Syndrome and Acromegaly Treatment Revenue in Global Market (2017-2022)
  7.5.5 HRA Pharma Key News
7.6 Ipsen Biopharmaceuticals
  7.6.1 Ipsen Biopharmaceuticals Corporate Summary
  7.6.2 Ipsen Biopharmaceuticals Business Overview
  7.6.3 Ipsen Biopharmaceuticals Cushing's Syndrome and Acromegaly Treatment Major Product Offerings
  7.6.4 Ipsen Biopharmaceuticals Cushing's Syndrome and Acromegaly Treatment Revenue in Global Market (2017-2022)
  7.6.5 Ipsen Biopharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cushing's Syndrome and Acromegaly Treatment Market Opportunities & Trends in Global Market
Table 2. Cushing's Syndrome and Acromegaly Treatment Market Drivers in Global Market
Table 3. Cushing's Syndrome and Acromegaly Treatment Market Restraints in Global Market
Table 4. Key Players of Cushing's Syndrome and Acromegaly Treatment in Global Market
Table 5. Top Cushing's Syndrome and Acromegaly Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cushing's Syndrome and Acromegaly Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cushing's Syndrome and Acromegaly Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cushing's Syndrome and Acromegaly Treatment Product Type
Table 9. List of Global Tier 1 Cushing's Syndrome and Acromegaly Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cushing's Syndrome and Acromegaly Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cushing's Syndrome and Acromegaly Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cushing's Syndrome and Acromegaly Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cushing's Syndrome and Acromegaly Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cushing's Syndrome and Acromegaly Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Cushing's Syndrome and Acromegaly Treatment Product Offerings
Table 32. Pfizer Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Cushing's Syndrome and Acromegaly Treatment Product Offerings
Table 35. Novartis Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Corporate Summary
Table 37. Bristol-Myers Squibb Cushing's Syndrome and Acromegaly Treatment Product Offerings
Table 38. Bristol-Myers Squibb Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Corcept Therapeutics Corporate Summary
Table 40. Corcept Therapeutics Cushing's Syndrome and Acromegaly Treatment Product Offerings
Table 41. Corcept Therapeutics Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), (2017-2022)
Table 42. HRA Pharma Corporate Summary
Table 43. HRA Pharma Cushing's Syndrome and Acromegaly Treatment Product Offerings
Table 44. HRA Pharma Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Ipsen Biopharmaceuticals Corporate Summary
Table 46. Ipsen Biopharmaceuticals Cushing's Syndrome and Acromegaly Treatment Product Offerings
Table 47. Ipsen Biopharmaceuticals Cushing's Syndrome and Acromegaly Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cushing's Syndrome and Acromegaly Treatment Segment by Type in 2021
Figure 2. Cushing's Syndrome and Acromegaly Treatment Segment by Application in 2021
Figure 3. Global Cushing's Syndrome and Acromegaly Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cushing's Syndrome and Acromegaly Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cushing's Syndrome and Acromegaly Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cushing's Syndrome and Acromegaly Treatment Revenue in 2021
Figure 8. By Type - Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 12. US Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 24. China Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cushing's Syndrome and Acromegaly Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cushing's Syndrome and Acromegaly Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Cushing's Syndrome and Acromegaly Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Cushing's Syndrome and Acromegaly Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Cushing's Syndrome and Acromegaly Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Corcept Therapeutics Cushing's Syndrome and Acromegaly Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. HRA Pharma Cushing's Syndrome and Acromegaly Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Ipsen Biopharmaceuticals Cushing's Syndrome and Acromegaly Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)